RIPK3_HUMAN - dbPTM
RIPK3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RIPK3_HUMAN
UniProt AC Q9Y572
Protein Name Receptor-interacting serine/threonine-protein kinase 3
Gene Name RIPK3
Organism Homo sapiens (Human).
Sequence Length 518
Subcellular Localization Cytoplasm, cytosol . Cell membrane. Mitochondrion .
Protein Description Essential for necroptosis, a programmed cell death process in response to death-inducing TNF-alpha family members. Upon induction of necrosis, RIPK3 interacts with, and phosphorylates RIPK1 and MLKL to form a necrosis-inducing complex. RIPK3 binds to and enhances the activity of three metabolic enzymes: GLUL, GLUD1, and PYGL. These metabolic enzymes may eventually stimulate the tricarboxylic acid cycle and oxidative phosphorylation, which could result in enhanced ROS production..
Protein Sequence MSCVKLWPSGAPAPLVSIEELENQELVGKGGFGTVFRAQHRKWGYDVAVKIVNSKAISREVKAMASLDNEFVLRLEGVIEKVNWDQDPKPALVTKFMENGSLSGLLQSQCPRPWPLLCRLLKEVVLGMFYLHDQNPVLLHRDLKPSNVLLDPELHVKLADFGLSTFQGGSQSGTGSGEPGGTLGYLAPELFVNVNRKASTASDVYSFGILMWAVLAGREVELPTEPSLVYEAVCNRQNRPSLAELPQAGPETPGLEGLKELMQLCWSSEPKDRPSFQECLPKTDEVFQMVENNMNAAVSTVKDFLSQLRSSNRRFSIPESGQGGTEMDGFRRTIENQHSRNDVMVSEWLNKLNLEEPPSSVPKKCPSLTKRSRAQEEQVPQAWTAGTSSDSMAQPPQTPETSTFRNQMPSPTSTGTPSPGPRGNQGAERQGMNWSCRTPEPNPVTGRPLVNIYNCSGVQVGDNNYLTMQQTTALPTWGLAPSGKGRGLQHPPPVGSQEGPKDPEAWSRPQGWYNHSGK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSCVKLWPS
------CCCEEECCC
27.84-
5Ubiquitination---MSCVKLWPSGAP
---CCCEEECCCCCC
49.5129967540
55UbiquitinationAVKIVNSKAISREVK
EEEEECHHHHCHHHH
44.5329967540
164PhosphorylationKLADFGLSTFQGGSQ
EHHHHCCCEECCCCC
27.79-
170PhosphorylationLSTFQGGSQSGTGSG
CCEECCCCCCCCCCC
28.1828348404
172PhosphorylationTFQGGSQSGTGSGEP
EECCCCCCCCCCCCC
39.7728348404
174PhosphorylationQGGSQSGTGSGEPGG
CCCCCCCCCCCCCCC
33.1628348404
176PhosphorylationGSQSGTGSGEPGGTL
CCCCCCCCCCCCCCC
39.5628348404
182PhosphorylationGSGEPGGTLGYLAPE
CCCCCCCCCEEECCH
23.9529883609
199PhosphorylationVNVNRKASTASDVYS
EECCCCCCCHHHHHH
27.7819524512
224PhosphorylationGREVELPTEPSLVYE
CCCEECCCCCHHHHH
73.4826657352
227PhosphorylationVELPTEPSLVYEAVC
EECCCCCHHHHHHHH
25.0026657352
230PhosphorylationPTEPSLVYEAVCNRQ
CCCCHHHHHHHHCCC
11.9428796482
241PhosphorylationCNRQNRPSLAELPQA
HCCCCCCCHHHCCCC
36.6523312004
252PhosphorylationLPQAGPETPGLEGLK
CCCCCCCCCCHHHHH
26.2823312004
267PhosphorylationELMQLCWSSEPKDRP
HHHHHHCCCCCCCCC
24.6723879269
268PhosphorylationLMQLCWSSEPKDRPS
HHHHHCCCCCCCCCC
33.1623879269
299PhosphorylationNNMNAAVSTVKDFLS
HCHHHHHHHHHHHHH
23.82-
300PhosphorylationNMNAAVSTVKDFLSQ
CHHHHHHHHHHHHHH
25.61-
316PhosphorylationRSSNRRFSIPESGQG
HHCCCCCCCCCCCCC
35.1122617229
320PhosphorylationRRFSIPESGQGGTEM
CCCCCCCCCCCCCCC
30.9428450419
325PhosphorylationPESGQGGTEMDGFRR
CCCCCCCCCCHHHHH
34.6529978859
333PhosphorylationEMDGFRRTIENQHSR
CCHHHHHHHHHCCCC
28.5228450419
339PhosphorylationRTIENQHSRNDVMVS
HHHHHCCCCCHHHHH
24.0223401153
359PhosphorylationLNLEEPPSSVPKKCP
CCCCCCCCCCCCCCC
55.4724719451
360PhosphorylationNLEEPPSSVPKKCPS
CCCCCCCCCCCCCCC
48.4928348404
367PhosphorylationSVPKKCPSLTKRSRA
CCCCCCCCCCHHHHH
59.1326657352
372PhosphorylationCPSLTKRSRAQEEQV
CCCCCHHHHHCHHHC
33.26-
389PhosphorylationAWTAGTSSDSMAQPP
HHHCCCCCCCCCCCC
33.2821601212
401PhosphorylationQPPQTPETSTFRNQM
CCCCCCCCCCCCCCC
33.98-
410PhosphorylationTFRNQMPSPTSTGTP
CCCCCCCCCCCCCCC
35.1523401153
412PhosphorylationRNQMPSPTSTGTPSP
CCCCCCCCCCCCCCC
43.1726657352
413PhosphorylationNQMPSPTSTGTPSPG
CCCCCCCCCCCCCCC
28.3728450419
414PhosphorylationQMPSPTSTGTPSPGP
CCCCCCCCCCCCCCC
47.7728450419
416PhosphorylationPSPTSTGTPSPGPRG
CCCCCCCCCCCCCCC
22.2328450419
418PhosphorylationPTSTGTPSPGPRGNQ
CCCCCCCCCCCCCCC
42.1830624053
467O-linked_GlycosylationVGDNNYLTMQQTTAL
ECCCCEEEEEEECCC
11.5430770249
486MethylationLAPSGKGRGLQHPPP
CCCCCCCCCCCCCCC
46.24115389587
496PhosphorylationQHPPPVGSQEGPKDP
CCCCCCCCCCCCCCH
25.8728450419

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
182TPhosphorylationKinaseRIPK3Q9Y572
PSP
199SPhosphorylationKinaseRIPK3Q9Y572
GPS
227SPhosphorylationKinaseRIPK3Q9Y572
PSP
-KUbiquitinationE3 ubiquitin ligaseBIRC2Q13490
PMID:21931591
-KUbiquitinationE3 ubiquitin ligaseBIRC3Q13489
PMID:21931591

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
48Kubiquitylation

21931591
182TPhosphorylation

29883609
182Tubiquitylation

29883609
199SPhosphorylation

11734559
227SPhosphorylation

22265413

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RIPK3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RIPK1_HUMANRIPK1physical
10339433
TCAM1_HUMANTICAM1physical
15064760
TNR1A_HUMANTNFRSF1Aphysical
10339433
CTND1_HUMANCTNND1physical
21903422
CDC37_HUMANCDC37physical
21903422
FKBP4_HUMANFKBP4physical
21903422
FKBP5_HUMANFKBP5physical
21903422
INP5K_HUMANINPP5Kphysical
21903422
PYGL_HUMANPYGLphysical
21903422
RIPK1_HUMANRIPK1physical
21903422
STIP1_HUMANSTIP1physical
21903422
RIPK1_HUMANRIPK1physical
22864571
FADD_HUMANFADDphysical
22864571
EPHA4_HUMANEPHA4physical
26186194
ZG16B_HUMANZG16Bphysical
26186194
PTPRK_HUMANPTPRKphysical
26186194
DAXX_HUMANDAXXphysical
23260419
RIPK1_HUMANRIPK1physical
25882049
RIPK1_HUMANRIPK1physical
24098568
RIPK1_HUMANRIPK1physical
26786097
FADD_HUMANFADDphysical
26786097
RIPK3_HUMANRIPK3physical
27045108
EPHA4_HUMANEPHA4physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RIPK3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Receptor interacting protein kinase-3 determines cellular necroticresponse to TNF-alpha.";
He S., Wang L., Miao L., Wang T., Du F., Zhao L., Wang X.;
Cell 137:1100-1111(2009).
Cited for: FUNCTION, PHOSPHORYLATION AT SER-199, AND INTERACTION WITH RIPK1.
"Identification of a novel homotypic interaction motif required forthe phosphorylation of receptor-interacting protein (RIP) by RIP3.";
Sun X., Yin J., Starovasnik M.A., Fairbrother W.J., Dixit V.M.;
J. Biol. Chem. 277:9505-9511(2002).
Cited for: RIP HOMOTYPIC INTERACTION MOTIF, PHOSPHORYLATION AT SER-199, ANDINTERACTION WITH RIPK1.

TOP